InnovHeart, developer of novel transcatheter mitral valve replacement (TMVR) sys...

JIM 2022 moves to June slot

Organisers of the Joint Interventional Meeting (JIM) have announced that the 202...
The first patient has been enrolled in the TRANSFORM II randomised controlle...
Radiation exposure during percutaneous coronary intervention (PCI) has fallen “c...
Researchers have warned that the number of people suffering from aortic valve st...
The US Food and Drug Administration (FDA) has issued two final guidances providi...
Congenita has been named a recipient of the MedTech NAVIGATOR Innovation Grant S...
A review evaluating the results of thoracic endovascular aortic repair (TEVA...
New clinical practice guidelines have been published today, and are intended to ...
CytoSorbents has called attention to a new publication which reports on the use ...
Cardiovascular Systems (CSI) and OrbusNeich Medical Company have announced US Fo...
WL Gore & Associates has announced that its Cardioform Septal Occluder h...
In a joint programme between the Society of Thoracic Surgeons (STS) and the ...
A new study reports that watching TV for four hours a day or more is associated ...
Royal Philips today announced physicians will now have access to advanced ne...
New guidelines from the American College of Cardiology (ACC) and the American He...
Cardiovascular Systems recently announced that it has made significant progress ...
A propensity score-matched analysis of the early outcomes of transcatheter aorti...
A 57-year-old patient with terminal heart disease received a successful transpla...
The American Association for Thoracic Surgery (AATS) and The Society of Thoracic...
The Society of Thoracic Surgeons (STS) has moved its 2022 annual meeting from an...
Terumo Medical Corporation has welcomed the publication of updated guidelines fr...
Robocath has announced the conclusion of its R-Evolution clinical study in Europ...
Regulators in three countries have granted approvals to Impella surgical product...
Medtronic has announced that the National Medical Products Administration (N...
The most read stories from December 2021 include analysis of the CHEETAH study a...
Neovasc has announced enrolment of the first patient in the COSIRA-II clinical t...
Endotronix has announced that the US Food and Drug Administration (FDA) has ...
Biomodex and the Montreal Heart Institute (MHI, Montreal, Canada) are partne...
Vesalio recently announced the start of enrolment in its NATURE study using enVa...
Royal Philips has announced US Food and Drug Administration (FDA) de novo cl...
Foldax has announced publication of the first clinical results for its Tria ...
Edwards Lifesciences has received approval from the US Food and Drug Adminis...
Doctors at St David's Medical Center in Austin, USA recently implanted a new neu...
Many patients undergoing cardiac surgery may be able to safely and effectively c...
FAST BioMedical has announced the publication of additional results from the EMP...
Thubrikar Aortic Valve has received approval from a Competent Authority in Polan...
Ultromics has announced the publication of a study assessing its EchoGo plat...
HeartFlow has announced it has submitted a 510(k) premarket application to the U...
Results of the CHEETAH clinical study highlight the potential role of mechan...
Svelte Medical Systems has received US Food and Drug Administration (FDA) approv...
Opsens has filed a 510(k) submission with the US Food & Drug Administration ...
The Society of Thoracic Surgeons (STS) has appointed Joanna Chikwe (chair of the...
The likelihood of patients with suspected or known coronary artery disease dying...
Huge strides have been made in preventing contrast-associated acute kidney i...
New guidelines for coronary artery revascularisation recommend that treatment de...
A team led by investigators at Massachusetts General Hospital (MGH) in Boston, U...
RSIP Vision has announced a new coronary artery modelling technology, which enab...
Royal Philips has announced an expansion of its ultrasound portfolio with ne...
Foldax has announced that the Drugs Controller General of India (DCGI), India’s ...
Venus Medtech has announced its acquisition of Cardiovalve, a transcatheter mitr...
SyMap Medical has announced the completion of a financing round which will b...
Restore Medical has announced preliminary results of the first-in-human clinical...
 The first analysis of findings from the bRIGHT registry, detailing rea...
One in 10 junior doctors training to be cardiologists in the UK say they have be...
Interim results from the REVERSE-IT trial of bentracimab (PhaseBio Pharmaceu...
Featuring stories from the Transcatheter Cardiovascular Therapeutics annual meet...
A novel artificial intelligence (AI) algorithm that identifies a cardiac dysfunc...
Soundbite Medical Solutions has announced that the US Patent and Trademark Offic...
Robocath has announced the successful completion of what it has described as the...
Findings of the CHOICE MI registry show that transcatheter mitral valve impl...
Findings from an on-treatment major bleeding analysis from the ENVISAGE TAVI...

Mirvat Alasnag

Mirvat Alasnag is the Gulf region’s first female interventional cardiologist. Cu...
Cardiovascular Systems has initiated a voluntary recall of unused Wirion embolic...
First clinical results of transcatheter aortic valve implantation (TAVI) usi...
The first 30-day results following the implantation of the NeoChord NeXuS tr...
Opsens has announced the successful treatment of 20 patients leading to the comp...
The Minneapolis Heart Institute Foundation (MHIF; Minneapolis, USA) has announce...
The first patients have been enrolled in the FAST III trial at the Erasmus Unive...
European Society of Cardiology (ESC) guidance for the diagnosis and management o...
New guidance on the diagnosis and presentation of cardiogenic shock aims to ...
A meta-analysis comparing percutaneous coronary intervention (PCI) using a d...
Nonagenarians should not be refused transcatheter aortic valve implantation (TAV...
An updated risk score to predict possible contrast-associated acute kidney i...
Use of a novel, venous external support device (VEST, Vascular Graft Solutio...
HeartVista has received US Food and Drug Administration (FDA) 510(k) clearance t...
Coronary artery bypass graft sugery (CABG) between two and three days after tica...
Asymptomatic patients with severe aortic stenosis (AS) may benefit from early ao...

What to expect from AHA 2021

Ahead of the American Heart Association’s 2021 annual scientific sessions (AHA 2...
This advertorial is sponsored by iVascular Treatment of a chronic total occlu...
Early data presented at the Transcatheter Cardiovascular Therapeutics annual...
Caption Health and Ultromics have announced a strategic partnership to accelerat...
Abbott has released new research from its Beyond Intervention initiative, a mult...
SIS Medical AG has appointed Ron Waksman, associate director Division of Car...

Lessons from SURTAVI

Transcatheter aortic valve implantation (TAVI) pioneer and principal investigato...
Cardiovascular Systems has announced the start of enrolment in a first in-human ...
Patients who went into cardiac arrest in the cardiac cath lab were more likely t...
CoreMedic has announced the publication of two-year follow-up results from the f...
Medtronic has announced its ambition to achieve net zero carbon emissions by fis...
Data from the BIOSOLVE-IV trial, presented at the Transcatheter Cardiovascul...
Six-month results from the TRISCEND study of the Evoque (Edwards Lifescience...
Early data for the self-expanding Intrepid (Medtronic) transcatheter mitral ...
Findings of the SWISS-APERO trial, presented at the Transcatheter Cardiovasc...
Patients receiving antiplatelet therapy following percutaneous coronary inte...
The final results of the PROTECT III and Restore EF prospective studies demo...
Left atrial appendage occlusion (LAAC) remains non-inferior to non vitamin-K...
Five-year clinical and echocardiographic outcome data from the SURTAVI rando...
Results from the largest randomised trial to date comparing different closur...
An economic analysis of data from the PARTNER 3 randomised trial, comparing ...
Penumbra has announced that the CHEETAH clinical study of its Indigo system ...
One-year outcomes from the Disrupt CAD III clinical study of Shockwave intravasc...
Results from SUGAR, a randomised controlled, multicentre trial conducted exclusi...
Randomised placebo-controlled trials show consistently that renal denervation pr...
Six-month outcomes from the randomised RADIANCE-HTN TRIO trial, comparing en...
Lesion selection for percutaneous coronary intervention (PCI) using the non-inva...
Percutaneous coronary intervention (PCI) guided by fractional flow reserve (...
Medtronic has announced findings from a new study of patient preferences for the...
In this issue:  MASTER DAPT game changing for short-duration dual antiplate...
In this issue:  MASTER DAPT game changing for short-duration dual antiplate...
Royal Philips has previewed updates in its product portfolio and new data due to...
Procyrion has announced the presentation of studies at the Transcatheter Cardiov...
Hypertension health-tech firm Aktiia has announced a US$17.5 million Series ...
ReValve Solutions has announced that it has successfully completed the first-in-...
Results from two studies of the Impella heart pump device will be presented at t...
This educational supplement, sponsored by Medtronic, explores the latest evidenc...
Joint clinical practice guidelines have been issued by the American Heart Associ...
Speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACT...
The longest available real-world follow-up data of transcatheter mitral ...
Teleflex announced the completion of patient enrolment in a clinical study evalu...
Patients who survive an aortic dissection often fail to receive ​​comprehens...
The Cardiovascular Research Foundation (CRF) has announced that the digital comp...
Sinomed has announced that the PIONEER III clinical trial results for its HT...
Cardiac CT angiography (CTA) derived left atrium emptying fraction (LAEF) im...
JenaValve Technology has announced the first commercial implants with the Trilog...
HeartFlow has announced the commencement of the REVEALPLAQUE trial to evaluate t...
The expansion of transcatheter aortic valve implantation (TAVI) in the USA has p...
Ethnic and racial minority cardiologists report career satisfaction but face pro...
“We are at the beginning of a type A dissection revolution,” Joseph E Bavari...
The underrepresentation of women in clinical coronary revascularisation tria...
OpSens has announced the commencement of the human clinical study utilising the ...
Building and maintaining expertise in both open and endovascular surgical te...
ReCor Medical has announced that its Paradise ultrasound renal denervation syste...
Baylis Medical Company has reached an agreement to sell its cardiology business ...
In a session on “Reduction of radiation challenges” at CX Aortic Vienna 2021...
Bert van Meurs is the chief business leader for Image Guided Therapy within Roya...
A decisive vote at CX Aortic Vienna 2021 (5–7 October, broadcast) revealed t...
Results of a poll conducted at CX Aortic Vienna 2021 (5–7 October, broadcast...
A worldwide committee of 40 cross-specialty medical experts achieved the fir...
NeoChord has announced successful completion of the first-in-human procedure wit...
Top stories for September included more highlights from the European Society of ...
Royal Philips and Lankenau Heart Institute part of Main Line Health (Wynnewood, ...
The US Food and Drug Administration (FDA) has informed healthcare providers of r...
Foldax has announced completion of enrolment in the US early feasibility study o...
Cardiovascular Systems recently announced that the first patient has been succes...
Siemens Healthineers has launched the Luminos Impulse fluoroscopy system, includ...
Abbott has announced that the US Food and Drug Administration (FDA) has approved...
Biotronik has announced that it has received US Food and Drug Administration...
Patients awaiting coronary artery bypass grafting (CABG) or percutaneous cor...
Open Stent Solution (OSS) has announced the closing of a €2.5 million Seed finan...
The Heart Rhythm Society (HRS) has announced that its cardiovascular digital hea...
Capturing the latest developments in the comprehensive treatment of aortic disea...
This advertorial is sponsored by Medtronic As transcatheter aortic valve ...
 George Dangas (New York, USA) discusses the results of the TWILIGHT-Stent tri...
Neovasc has announced that it has received Food and Drug Administration (FDA) ap...
Abbott has announced that the US Food and Drug Administration (FDA) has approved...
Patients at low surgical risk who had undergone transcatheter aortic valve i...
A cardiothoracic surgical team with UofL Health–Jewish Hospital and the Univ...
Ultrasound-guided transfemoral transcatheter aortic valve implantation (TAVI...
Randomised trials are needed to evaluate the safety and effectiveness of tra...
Abbott has announced that the US Food and Drug Administration (FDA) has appr...
OpSens has announced that it has received Health Canada approval to commence the...
Following the release of the European Society of Hypertension’s (ESH’s) upda...
One-year data from preclinical trials of Xeltis restorative coronary artery bypa...
The Cardiovascular Research Foundation (CRF) has announced 22 late-breaking ...
European Society of Hypertension (ESH), the leading hypertension (HTN) society i...
Peijia Medical has announced the initiation of its multicentre clinical tria...

Christoph Naber

Christoph Naber (Essen, Germany) talks to Cardiovascular News about his career i...
Four-dimensional (4D) flow magnetic resonance imaging (MRI) has the potentia...
CytoSorbents has filed an investigational device exemption (IDE) application to ...
STENTiT, a medical device company bringing a novel class of regenerative end...
When a modified surgical technique was used to gently remove sections of leg vei...
Concept Medical has announced the enrolment of the thousandth patient in ABILITY...
“During a heart attack time is myocardium,” says Annapoorna Kini (New York, ...
Adults younger than 45 years who reported recently using cannabis were two times...
August’s top 10 features a stark warning over representation of women in clinica...
HeartFlow has announced that physicians at Erasmus MC Hospital (Rotterdam, T...
Findings of the STOPDAPT-2 ACS trial presented during a hot line session at ...
Abbott has announced late-breaking data from the Amulet LAA Occluder IDE tri...
Work stress, sleep disorders, and fatigue—which are regarded as non-traditional ...
 Marco Valgimigli (Lugano, Switzerland) talks to Cardiovascular News abo...
Adding systematic fractional flow reserve (FFR) assessment to coronary angio...
MedAlliance today announced first patient enrolment in the coronary randomised c...
Early coronary angiography in out-of-hospital cardiac arrest (OHCA) patients...
Edoxaban is noninferior to warfarin and its analogues for adverse clinical e...
One month of dual antiplatelet therapy (DAPT) following stent implantation i...
The world’s first feasibility study has found that drones can be used to deliver...
The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatm...
Adherence to lifestyle advice and medications could add seven healthy years of l...
CARMAT has announced the second centre implanting its bioprosthetic artificial h...
Medtronic has announced US Food and Drug Administration (FDA) approval of its ne...
Young heart attack victims are more likely to be smokers, obese, and have hi...
Cardiac Dimensions has announced the launch of the US pivotal study the EMPO...
Readmissions within 30 days are more common following urgent, rather than el...
In this issue: Meta analysis draws out debate on coronary revascularisation...
In this issue: Meta analysis draws out debate on coronary revascularisation...
Translumina has announced the publication of 10-year clinical outcome data for i...
Ultromics, a developer of AI enabled cardiovascular imaging solutions, has annou...
The US Food and Drug Administration (FDA) has granted breakthrough device de...
Biotronik has announced the results from a new study published in EP Europace th...
Sinomed has announced the first commercial implantation of the HT Supreme dr...
Physicians at Mount Sinai Health System (New York, USA) have developed a mobile ...
CytoSorbents has been granted a second breakthrough device designation for its D...
Abbott has announced that the US Food and Drug Administration (FDA)  has app...
Occlutech Holding has announced the conditional US Food and Drug Administration ...
An imaging technology developed using artificial intelligence (AI) could become ...
Caption Health has announced that the Centers for Medicare and Medicaid Serv...
Women remain underrepresented in cardiovascular clinical trials despite initiati...
RealView Imaging has announced that it has received US Food and Drug Administrat...
With the COVID-19 pandemic having switched virtually all of the major meetin...
Our top 10 stories of July 2021, including: A milestone for coronary balloon ang...
The largest analysis of its kind to look at the impact of COVID-19 on adult ...
Abbott has announced that it has received US Food and Drug Administration (FDA) ...
Edwards Lifesciences has announced that it has received regulatory approval from...
The USA saw a 10% decline in percutaneous coronary intervention (PCI) proced...
Angel Medical Systems (AngelMed) has announced the first commercial implantation...
An analysis of the rates rehospitalisation and mortality in heart failure pa...
Medtronic has announced the launch of the Prevail drug coated balloon (DCB) cath...
This advertorial is sponsored by Medtronic The first case using the Preva...
CathWorks has announced that the Japanese Ministry of Health, Labour and Wel...
Among patients undergoing mitral valve surgery after failed transcatheter ed...
Clinical and economic results from the 3M TAVR economic study have been pres...
Patients with bicuspid aortic stenosis may benefit as much from transcathete...
Two-year results from the PINNACLE FLX clinical trial assessing the safety and e...
MedAlliance has launched Origin SC and Origin NC, two high performance balloons ...
Ancora Heart has closed US$80 million in equity financing, with the funds to...
HeartFlow has entered into a definitive business combination agreement with ...
Carmat has announced the first implantation of its bioprosthetic artificial hear...
Patients undergoing permanent pacemaker implantation after surgical aortic v...
atHeart Medical has announced the successful treatment of the first five pat...
East End Medical has announced it has received US Food and Drug Administrati...
Global action is needed to improve clinician wellbeing, according to four leadin...
Xeltis has announced that it has started a pivotal trial for a synthetic restora...
The American Heart Association (AHA) has published a scientific statement ch...
Our top 10 stories of June 2021, including: Analysis of the data for transcathet...
CytoSorbents has received approval for its investigational device exemption (IDE...
Carta Healthcare has announced that it has been certified as a National Cardiova...
Sinomed has announced a partnership with the National University of Ireland ...
Assessment of patients by both interventional cardiologists and cardiac surg...
Royal Philips has announced the first procedure using its real-time 3D intracard...
Abbott has today announced that its Xience family of stents has received US ...
Clinical practice guidance released today outline recommendations for reduci...
Electroducer has announced that it has raised €3 million (US$3.65M) from private...
The risk of heart damage from COVID-19 infection is far greater than that from r...
Heart attacks during the COVID-19 pandemic were more likely to result in hea...
Angel Medical Systems (AngelMed) has announced US Food and Drug Administration (...
Nearly one in eight coronary artery bypass graft (CABG) patients are readmit...
The first end-to-end remotely guided transcatheter aortic valve implantation...
Abbott has received Breakthrough Device designation from the US Food and Dru...
Royal Philips has announced the official start of the DEFINE GPS study, with...
After speaking with experts, reviewing current evidence, surveying people living...
Data captured in the National Cardiovascular Data Registry (NCDR) is similar...
An investigation into the impact of postoperative complications on long-term qua...

Cindy Grines

Cindy Grines is an interventional cardiologist and chief scientific officer of N...
In patients with acute coronary syndrome treated with percutaneous coronary ...
The number of people dying from cardiovascular disease (CVD) in Asia is increasi...
CorWave has announced that it has successfully completed the first 90-day precli...
Circulation the flagship journal of the American Heart Association (AHA) has pub...
Shockwave Medical has announced today that the Centers for Medicare & Medica...
A study looking at the timing of coronary artery bypass grafting (CABG) after th...
Pivotal trials of transcatheter aortic valve implantation (TAVI) in low-risk...
Neurescue has announced that the US Food and Drug Administration (FDA) has grant...
A new physiological measurement of heart function could improve survival for...
Early experience with the Evoque (Edwards Lifesciences) tricuspid valve replacem...
GE Healthcare is collaborating with the American College of Cardiology (ACC) thr...
Medtronic is stopping the distribution and sale of the Medtronic HVAD system...
This advertorial is sponsored by Sinomed As newer-generation drug-eluting...
Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about th...
 John Forrest (New Haven, USA) sits down with Cardiovascular News to talk ab...
Our top 10 stories of May 2021, including highlights from both EuroPCR 2021 (18–...
There does not appear to be a relationship between operator and patient gender a...
Siemens Healthineers has announced that it has received CE Mark for the AcuNav V...
LivaNova has successfully completed the initial closing of the divestiture o...
Women who experience acute aortic dissection are older, have more advanced d...
Abiomed has acquired preCARDIA, developer of a proprietary catheter and controll...
Sinomed has announced results from the HT Supreme healing-targeted drug-elut...
There is an increasing understanding of the need for tailored strategies when tr...
A call for greater investment in surgical facilities in the UK in the wake of th...
Interventional cardiologists from across the globe are joining forces for a ...
This advertorial is sponsored by Shockwave Medical. Severe coronary artery ca...
The European Union (EU) Medical Devices Regulation (MDR) takes effect from today...
Foldax has announced the successful first-in-human use of its biopolymer Tria he...
Procyrion has announced the treatment of the first patients in the pilot trial t...
 Ajay Kirtane (New York, USA) talks to Cardiovascular News about the RADIANC...
Investigation of the use of an ultra-thin strut biopolymer sirolimus-eluting...
This advertorial is sponsored by Boston Scientific In recent years, trans...
OrbusNeich and P&F Products & Features, under the joint partnership Orbu...
Results of an observational study using optical coherence tomography (OCT) t...
One-year results of the FUTURE-II study—a randomised trial comparing a thin-...
A meta-analysis of randomised trials comparing a strategy of revascularisation p...
Clopidogrel monotherapy produced better outcomes than aspirin for the long-t...
HeartFlow has announced new data which indicate that the information provide...
Rivaroxaban (Xarelto, Bayer/Janssen), in addition to low-dose aspirin, shoul...
Complete two-year follow-up data from the Evolut Low Risk trial, presented d...
Long-term follow-up data from the BIOSOLVE-IV registry, presented at the Eur...
This advertorial is sponsored by PIE Medical Findings of the multicentre ...
Data presented at hotline and late-breaking trial sessions at the EuroPCR 20...
Royal Philips has announced the European availability of new innovations in its ...
ZOLL Medical Corporation has announced that the US Food and Drug Administrat...
Abbott has announced it has received CE mark for its latest-generation transcath...
Among patients with suspected acute coronary syndrome (ACS), the use of a hi...
The proportion of cardiologists reporting burnout has nearly doubled during ...
ST-elevation Myocardial Infarction (STEMI) patients with multi-vessel diseas...
Switching from ticagrelor to clopidogrel dual antiplatelet therapy (DAPT) af...
Transcatheter left atrial appendage occlusion (LAAO) with a Watchman (Boston...
Apixaban was not superior to standard of care following transcatheter aortic...
Patients with an elevated risk of stroke due to arrhythmia or atrial fibrillatio...
CeloNova BioSciences that its COBRA PzF nanocoated coronary stent (NCS) achi...
Royal Philips has announced the integration of its Interventional Hemodynamic sy...
This advertorial is sponsored by Pi-Cardia As more transcatheter aortic valve...
This advertorial is sponsored by Osprey Medical There is a growing recognitio...
Discrimination and harassment are a common experience among those working in car...
In this issue: Hostile environment: How cardiologists feel about discrimina...
In this issue: Hostile environment: How cardiologists feel about disc...
Research presented at the American Association for Thoracic Surgery 101st Annual...
Fewer than half (48%) of patients undergoing percutaneous coronary intervent...
A significant proportion of cardiology trainees are uncomfortable with using...
Boston Scientific has announced it has initiated the AGENT IDE trial for the Age...
Mild COVID-19 infection is unlikely to cause lasting damage to the structure or ...
Abbott has announced a new trial focused on improving the treatment for people s...
Our top 10 stories of April 2021, including: highlights from the Society for Car...
ST-elevation myocardial infarction (STEMI) patients received percutaneous corona...
Timothy D Henry (The Christ Hospital Medical, Cincinnati, USA) has assumed t...
Patients suffering from severe mitral regurgitation should be carefully screened...
Medtronic has announced that it has received the CE mark for the Evolut PRO+...
Patients studied in the ISCHEMIA trial, the largest trial to date to compare...
Robotic-assisted percutaneous coronary intervention (PCI) using the second-g...
Analysis of the prospective Fuwai PCI Registry using selection criteria from the...
The Society for Cardiovascular Angiography and Interventions (SCAI) has released...
Two research papers presented at the Society for Cardiovascular Angiography ...
Medtronic has announced results from an interim analysis of the first 171 pa...
Patients hospitalised with COVID-19 may be at risk of developing heart failu...
Phoenix Cardiac Devices has announced that it has received CE mark for its Basal...
CytoSorbents has announced that the US Food and Drug Administration (FDA) has gr...
Initial findings from the North American Cardiovascular COVID-19 Myocardial ...
Abiomed has announced that the first patient has been enrolled in PROTECT IV...
Researchers from King's College London (London, UK) have created 3D replicas of ...
A retrospective observational study of patients undergoing cardiac surgery in th...
The work of the Cardiothoracic Surgical Trials Network (CTSN) in mobilising reso...
Acutus Medical has announced US Food and Drug Administration (FDA) clearance of ...
The first procedure has been completed in SMART (Small Annuli Randomized to ...
Abbott has received CE mark for its next-generation TriClip transcatheter tricus...
Our top 10 stories of March 2021, including: highlights from CRT 2021; convergin...
More patients, particularly those with medical risk factors or from underser...
With recent data pointing to a shift towards more transcatheter aortic valve imp...
Abbott has announced that its Xience stent has received CE mark in Europe fo...
Dipti Itchhaporia has today begun her term as president of the American Coll...
ClearFlow has announced clinical trial results published in the Journal of Cardi...
More than a third of female cardiologists polled in a UK survey on discriminatio...
Patients aged over 65 years were more likely than their younger counterparts to ...
Matheen Khuddus (director of Cardiovascular Research, The Cardiac & Vascular...
B Braun Interventional Systems has announced a collaboration with Infraredx to a...
Alvimedica has announced CE mark approval of Fluydo NC, its PTCA non-compliant b...
Medtronic has received US Food and Drug Administration (FDA) approval for its Ha...
Social media has become an important platform for promoting research within the ...
Endotronix has announced the 100th global implant of the Cordella pulmonary ...
Men with stable coronary artery disease who receive Viagra due to impotence ...
Shockwave Medical has announced that the company has signed an agreement to form...
Bristol Myers Squibb has announced that the US Food and Drug Administration (FDA...
 Speaking to Cardiovascular News, Georg Nickenig (Bonn, Germany) details the...

Stephan Achenbach

Stephan Achenbach is professor of medicine at the University of Erlangen, Erlang...
Three-year results from the COMPARE-ABSORB trial, presented during a late-br...
Three-year clinical outcomes from the Recre8 trial, a multicentre study comparin...
Lab-created heart valves implanted in young lambs were capable of growth wit...
Imbio has received US Food and Drug Administration (FDA) 510(k) clearance for it...
Cardiovascular Systems has announced that the first patients in the USA have bee...
CytoSorbents has announced the filing of an investigational device exemption (ID...
Elixir Medical has today announced commencement of the INFINITY-SWEDEHEART rando...
Ahmed Bendary (Benha University, Benha, Egypt) details the CardioRisk projec...
Two-year follow-up data the BIOSTEMI trial, presented during a late-breaking...
Thomas Pilgrim (Bern, Switerland) details two-year results from the BIOSTEMI r...
Clinical outcomes up to one year after transcatheter aortic valve implantati...
Five-year follow-up results from the Gore REDUCE study, assessing the Gore C...
The American College of Cardiology (ACC) has announced a number of the late-brea...
Registry data charting the use of direct oral anticoagulants (DOACs) in pati...
Data from an international registry of patients undergoing a procedure known...
Our top 10 stories of February 2021, including: the relationship between TAVI vo...
Following consultation with its notified body, MEDCERT GmbH, Abiomed is introduc...
ControlRad has announced US Food and Drug Administration (FDA) 510(k) cleara...
Favourable rates of ischaemic outcomes were observed among selected high ble...
A global collaboration between international heart failure bodies seeks to stand...
MedAlliance has been awarded breakthrough status for Selution SLR, its sustained...
Innovative Cardiovascular Solutions (ICS) has announced the success of its f...
Vascular Grafts Solutions has announced receipt of marketing clearance from the ...
Two-year outcomes of the PARTNER 3 clinical trial, in which low surgical ris...
An analysis of antiplatelet therapies used during percutaneous coronary inte...
A secondary analysis of the COAPT trial, which sought to account for differe...
Elucid, a developer of AI software to enable cardiovascular disease detection, h...
Inovise Medical has announced that the US Food and Drug Administration (FDA)...
Occlutech has announced the completion of patient enrolment in its pilot study t...
A sub-analysis of the DISRUPT CAD III clinical trial, investigating use of S...
After Shockwave Medical announced that its intravascular lithotripsy (IVL) techn...
Terumo Corporation has signed a definitive agreement to acquire all assets of He...
The American College of Cardiology (ACC) has announced that its 70th annual scie...
Urgent action is needed to address the growing burden of heart failure and t...
A sub-analysis of the Recre8 trial, assessing patients at high bleeding risk...
Caption Health has announced the publication of a study in JAMA Cardiology a...
OpSens has received CE mark approval for the OptoWire III, the latest generation...
Around 50% of patients who have been hospitalised with severe COVID-19 and h...
With the COVID-19 pandemic creating new barriers to the accessibility of hea...
Teleflex has announced the completion of patient enrolment in a clinical study e...
Shockwave Medical has announced that its intravascular lithotripsy (IVL) technol...
Dropping aspirin shortly after percutaneous coronary intervention (PCI) is a...
A study detailing early experience of the Pascal transcatheter valve system ...
Off-pump coronary artery bypass grafting (OPCABG) is a safe and effective option...
The number of patients with heart failure worldwide nearly doubled from 33.5 mil...
Robotic-assisted treatment is on the cusp of achieving its full potential, says ...
Updated recommendations on the optimal antithrombotic treatment of patients with...
The authors of a systematic review and meta-analysis, looking at the effect ...
MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its lar...
iVascular has announced that its Angiolite drug-eluting stent (DES) is available...
Royal Philips has announced that it has completed the acquisition of BioTelemetr...
Puzzle Medical has announced that the US Food and Drug Administration (FDA) has ...
Cardiovascular Systems has announced that the first patient in Europe has be...
COVID-19 patients who suffer a cardiac arrest either in or out of hospital are f...
Drug-eluting stent implantation guided by intravascular ultrasound (IVUS) is ass...
A study published in the Journal of Cardiac Surgery, detailing 18 out of a group...
Cardiovascular Systems (CSI) has partnered with Chansu Vascular Technologies...
Minimally invasive aortic valve replacement (miAVR) in select patients with ...
Forge Medical has announced the publication of results of an investigator-initia...
The risk of burnout among cardiothoracic surgeons has been heightened by the...
Cardiothoracic surgeon Sean C Grondin from the University of Calgary (Calgary, C...